[Cancer Lett. 2020] Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells.

Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells.

Park S, Kim TM, Cho SY, Kim S, Oh Y, Kim M, Keam B, Kim DW, Heo DS.

Cancer Lett. 2020 Dec 28;495:135-144. doi: 10.1016/j.canlet.2020.09.018. Epub 2020 Sep 23.PMID: 32979462

https://pubmed.ncbi.nlm.nih.gov/32979462/